Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.
paper
Cited
Public
Unavailable
- Authors
- Baranzini, Sergio E; Wang, Joanne; Gibson, Rachel A; Galwey, Nicholas; Naegelin, Yvonne; Barkhof, Frederik; Radue, Ernst-Wilhelm; Lindberg, Raija L P; Uitdehaag, Bernard M G; Johnson, Michael R; Angelakopoulou, Aspasia; Hall, Leslie; Richardson, Jill C; Prinjha, Rab K; Gass, Achim; Geurts, Jeroen J G; Kragt, Jolijn; Sombekke, Madeleine; Vrenken, Hugo; Qualley, Pamela; Lincoln, Robin R; Gomez, Refujia; Caillier, Stacy J; George, Michaela F; Mousavi, Hourieh; Guerrero, Rosa; Okuda, Darin T; Cree, Bruce A C; Green, Ari J; Waubant, Emmanuelle; Goodin, Douglas S; Pelletier, Daniel; Matthews, Paul M; Hauser, Stephen L; Kappos, Ludwig; Polman, Chris H; Oksenberg, Jorge R
- Year
- 2009
- Journal
- Human molecular genetics
- PMID
- 19010793
- DOI
- 10.1093/hmg/ddn388
- PMCID
- PMC4334814
Multiple sclerosis (MS), a chronic disorder of the central nervous system and common cause of neurological disability in young adults, is characterized by moderate but complex risk heritability. Here we report the results of a genome-wide association study performed in a 1000 prospective case series of well-characterized individuals with MS and group-matched controls using the Sentrix HumanHap550 BeadChip platform from Illumina. After stringent quality control data filtering, we compared allele frequencies for 551 642 SNPs in 978 cases and 883 controls and assessed genotypic influences on susceptibility, age of onset, disease severity, as well as brain lesion load and normalized brain volume from magnetic resonance imaging exams. A multi-analytical strategy identified 242 susceptibility SNPs exceeding established thresholds of significance, including 65 within the MHC locus in chromosome 6p21.3. Independent replication confirms a role for GPC5, a heparan sulfate proteoglycan, in disease risk. Gene ontology-based analysis shows a functional dichotomy between genes involved in the susceptibility pathway and those affecting the clinical phenotype.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | 2012 | 22064162 |
| A genome-wide scan for common alleles affecting risk for autism. | 2010 | 20663923 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Astrocytes and Alcohol Throughout the Lifespan. | Guizzetti M et al. | β | 2026 | β |
| Causal association between multiple sclerosis and trigeminal neuralgia: A Mendelian randomization study with meta-analysis. | Halboub E et al. | β | 2026 | β |
| Association of Functional Gene Variants in DYSF-ZNF638, MTSS1 and Ferroptosis-Related Genes with Multiple Sclerosis Severity and Target Gene Expression. | Djuric T et al. | β | 2025 | β |
| Decoding the molecular and cellular aspects of multiple sclerosis: From diagnosis to therapeutic strategies. | Gupta NS et al. | β | 2025 | β |
| Enhanced expression of miR-128 in peripheral blood mononuclear cells: a potent candidate diagnostic biomarker for multiple sclerosis. | Akhgari H et al. | β | 2025 | β |
| Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis. | Pukaj A et al. | β | 2025 | β |
| Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination. | Zhao-Fleming HH et al. | β | 2025 | β |
| Serum levels of tumor necrosis factor and TNFRSF1A gene polymorphisms in Egyptian multiple sclerosis patients: the influence on susceptibility and severity. | Naseer MA et al. | β | 2025 | β |
| Single-cell analysis of cerebrospinal fluid reveals common features of neuroinflammation. | Jacobs BM et al. | β | 2025 | β |
| The epidemiology, pathology and pathogenesis of MS: Therapeutic implications. | Goodin DS | β | 2025 | β |
| Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis. | Misicka E et al. | β | 2024 | β |
| Analysis of CNS autoimmunity in genetically diverse mice reveals unique phenotypes and mechanisms. | Nelson EA et al. | β | 2024 | β |
| Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model. | Censi ST et al. | β | 2024 | β |
| Genetic polymorphisms in IL-2, IL-10 and FOXP3 are associated with autoimmune neutropenia in early childhood and autoantibody specificity in a Danish cohort. | KlΓΈve-Mogensen K et al. | β | 2024 | β |
| Genome-wide association studies for economically important traits in mink using copy number variation. | Davoudi P et al. | β | 2024 | β |
| Machine Learning of Three-Dimensional Protein Structures to Predict the Functional Impacts of Genome Variation. | Shukla K et al. | β | 2024 | β |
| MicroRNAs targeting TGF-Ξ² signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function. | Rau CN et al. | β | 2024 | β |
| Probing the basis of disease heterogeneity in multiple sclerosis using genetically diverse mice | Holt EA et al. | β | 2024 | β |
| Recent advances in the treatment of primary and secondary progressive Multiple Sclerosis. | Sriwastava S et al. | β | 2024 | β |
| Should We Consider Neurodegeneration by Itself or in a Triangulation with Neuroinflammation and Demyelination? The Example of Multiple Sclerosis and Beyond. | Perdaens O et al. | β | 2024 | β |
| The complement system in neurodegenerative diseases. | Nimmo J et al. | β | 2024 | β |
| Two-Sample Mendelian Randomization Study Identifies Tissue-Dependent Risk Genes in Autoimmune Diseases. | Chiu R et al. | β | 2024 | β |
| A systematic review of Mendelian randomization studies on multiple sclerosis. | Fazia T et al. | β | 2023 | β |
| Comparison of recent updates in genetics, immunology, biomarkers, and neuroimaging of primary-progressive and relapsing-remitting multiple sclerosis and the role of ocrelizumab in the management of their refractory cases. | Prajjwal P et al. | β | 2023 | β |
| Epstein-Barr virus and genetic risk variants as determinants of T-bet<sup>+</sup> B cell-driven autoimmune diseases. | Bogers L et al. | β | 2023 | β |
| Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome. | Sahi N et al. | β | 2023 | β |
| Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials. | Loomis SJ et al. | β | 2023 | β |
| Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity. | Jokubaitis VG et al. | β | 2023 | β |
| Regulation of Biomolecular Condensates by Poly(ADP-ribose). | Rhine K et al. | β | 2023 | β |
| A Comparison of Methods for Gene-Based Testing That Account for Linkage Disequilibrium. | Cinar O et al. | β | 2022 | β |
| Analysis of selected polymorphisms in FOXP3 gene in a cohort of Egyptian patients with schizophrenia. | Mostafa M et al. | β | 2022 | β |
| Genetics and functional genomics of multiple sclerosis. | Kim W et al. | β | 2022 | β |
| Identification of genetic risk loci for depression and migraine comorbidity in Han Chinese residing in Taiwan. | Tsai MC et al. | β | 2022 | β |
| Increased Neurofilament Light Chain Is Associated with Increased Risk of Long-Term Mortality in Cerebral Small Vessel Disease. | Jacob MA et al. | β | 2022 | β |
| Large-scale genomic analyses reveal insights into pleiotropy across circulatory system diseases and nervous system disorders. | Zhang X et al. | β | 2022 | β |
| Multiple Sclerosis and Autoimmunity: A Veiled Relationship. | Barkhane Z et al. | β | 2022 | β |
| The "6B" strategy: Build Back a Better Blood-Brain Barrier. | Calvier L et al. | β | 2022 | β |
| TRIM family proteins: roles in proteostasis and neurodegenerative diseases. | Zhu Y et al. | β | 2022 | β |
| An integrative study of genetic variants with brain tissue expression identifies viral etiology and potential drug targets of multiple sclerosis. | Manuel AM et al. | β | 2021 | β |
| Association of MACROD2 gene variants with obesity and physical activity in a Korean population. | Kim HR et al. | β | 2021 | β |
| Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort. | Tsagkas C et al. | β | 2021 | β |
| Genetic susceptibility to multiple sclerosis in African Americans. | Goodin DS et al. | β | 2021 | β |
| Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regions. | Goodin DS et al. | β | 2021 | β |
| HLA-DQA1*04:01 is related to a higher multiple sclerosis lesion load on T2/Flair MRI sequences. | Noro F et al. | β | 2021 | β |
| Identification of candidate SNPs and genes associated with anti-RGNNV using GWAS in the red-spotted grouper, Epinephelus akaara. | Yang M et al. | β | 2021 | β |
| The nature of genetic and environmental susceptibility to multiple sclerosis. | Goodin DS et al. | β | 2021 | β |
| The SARS-CoV-2 as an instrumental trigger of autoimmunity. | Dotan A et al. | β | 2021 | β |
| An Intergenic rs9275596 Polymorphism on Chr. 6p21 Is Associated with Multiple Sclerosis in Latvians. | Paramonova N et al. | β | 2020 | β |
| An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population. | Okolicsanyi RK et al. | β | 2020 | β |
| Complex genetic dependencies among growth and neurological phenotypes in healthy children: Towards deciphering developmental mechanisms. | Uechi L et al. | β | 2020 | β |
| Dense module searching for gene networks associated with multiple sclerosis. | Manuel AM et al. | β | 2020 | β |
| Growth differentiation factor 15 is increased in stable MS. | Amstad A et al. | β | 2020 | β |
| Interactions among IGF-1, AKT2, FOXO1, and FOXO3 variations and between genes and physical activities on physical performance in community-dwelling elders. | Li TC et al. | β | 2020 | β |
| Involvement of Genetic Factors in Multiple Sclerosis. | FerrΓ¨ L et al. | β | 2020 | β |
| Levels of brain-derived neurotrophic factor in patients with multiple sclerosis. | Naegelin Y et al. | β | 2020 | β |
| Mammalian phospholipase D: Function, and therapeutics. | McDermott MI et al. | β | 2020 | β |
| Monitoring of radiologic disease activity by serum neurofilaments in MS. | Uher T et al. | β | 2020 | β |
| Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. | Fransen NL et al. | β | 2020 | β |
| Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors. | Misicka E et al. | β | 2020 | β |
| Reelin depletion protects against autoimmune encephalomyelitis by decreasing vascular adhesion of leukocytes. | Calvier L et al. | β | 2020 | β |
| Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis. | Mechelli R et al. | β | 2020 | β |
| The expression profile of virus-recognizing toll-like receptors in natural killer cells of Cypriot multiple sclerosis patients. | Deeba E et al. | β | 2020 | β |
| The Molecular and Pathophysiological Functions of Members of the LNX/PDZRN E3 Ubiquitin Ligase Family. | Hong J et al. | β | 2020 | β |
| Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population. | Simsek H et al. | β | 2019 | β |
| Association of <i>CD58</i> polymorphism and multiple sclerosis in Malaysia: a pilot study. | Ching YM et al. | β | 2019 | β |
| Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms. | Shepard CJ et al. | β | 2019 | β |
| Cumulative influence of parity-related genomic changes in multiple sclerosis. | Mehta D et al. | β | 2019 | β |
| Genome-wide association analysis of 19,629 individuals identifies variants influencing regional brain volumes and refines their genetic co-architecture with cognitive and mental health traits. | Zhao B et al. | β | 2019 | β |
| Genome-Wide Multiple Sclerosis Association Data and Coagulation. | La Starza S et al. | β | 2019 | β |
| Plasma proteome in multiple sclerosis disease progression. | Malekzadeh A et al. | β | 2019 | β |
| Poly(ADP-Ribosylation) in Age-Related Neurological Disease. | McGurk L et al. | β | 2019 | β |
| The gut microbiota perspective for interventions in MS. | Zoledziewska M | β | 2019 | β |
| The Multiple Sclerosis Severity Score: fluctuations and prognostic ability in a longitudinal cohort of patients with MS. | Gross RH et al. | β | 2019 | β |
| Uveitis and Multiple Sclerosis: Potential Common Causal Mutations. | de-la-Torre A et al. | β | 2019 | β |
| A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation. | Jacobsen FA et al. | β | 2018 | β |
| Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease. | FernΓ‘ndez MV et al. | β | 2018 | β |
| Genetics of Multiple Sclerosis: An Overview and New Directions. | Patsopoulos NA | β | 2018 | β |
| Genome-wide association studies of multiple sclerosis. | Cotsapas C et al. | β | 2018 | β |
| Genotype and Phenotype in Multiple Sclerosis-Potential for Disease Course Prediction? | Jokubaitis VG et al. | β | 2018 | β |
| Highly conserved extended haplotypes of the major histocompatibility complex and their relationship to multiple sclerosis susceptibility. | Goodin DS et al. | β | 2018 | β |
| Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions. | Paraboschi EM et al. | β | 2018 | β |
| Method to estimate the approximate samples size that yield a certain number of significant GWAS signals in polygenic traits. | Bacanu SA et al. | β | 2018 | β |
| Multiple sclerosis. | Cotsapas C et al. | β | 2018 | β |
| Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease. | Johnson SC | β | 2018 | β |
| Promising new therapeutic targets for regulation of inflammation and immunity: RING-type E3 ubiquitin ligases. | Bulatov E et al. | β | 2018 | β |
| Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis. | Barro C et al. | β | 2018 | β |
| Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression. | Voskuhl RR et al. | β | 2018 | β |
| Specific Alterations in Astrocyte Properties via the GluA2-GAPDH Complex Associated with Multiple Sclerosis. | Lee FHF et al. | β | 2018 | β |
| Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer's Disease. | Tandon A et al. | β | 2018 | β |
| The FOXP3 rs3761547 Gene Polymorphism in Multiple Sclerosis as a Male-Specific Risk Factor. | Wawrusiewicz-Kurylonek N et al. | β | 2018 | β |
| This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy. | Stroupe C | β | 2018 | β |
| TNFRSF1A polymorphisms and their role in multiple sclerosis susceptibility and severity in the Slovak population. | Javor J et al. | β | 2018 | β |
| Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis. | Harirchian MH et al. | β | 2018 | β |
| Age-associated DNA methylation changes in naive CD4<sup>+</sup> T cells suggest an evolving autoimmune epigenotype in aging T cells. | Dozmorov MG et al. | β | 2017 | β |
| Age Related Multiple Sclerosis Severity Score: Disability ranked by age. | Manouchehrinia A et al. | β | 2017 | β |
| Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus. | D'Amico F et al. | β | 2017 | β |
| Association of gene coding variation and resting metabolic rate in a multi-ethnic sample of children and adults. | Hellwege JN et al. | β | 2017 | β |
| Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter. | Hares K et al. | β | 2017 | β |
| Development of autoantibodies precedes clinical manifestations of autoimmune diseases: A comprehensive review. | Ma WT et al. | β | 2017 | β |
| Differential DNA Methylation in Monozygotic Twins Discordant for Female Sexual Functioning. | Burri A et al. | β | 2017 | β |
| Genetic factors affecting EBV copy number in lymphoblastoid cell lines derived from the 1000 Genome Project samples. | Mandage R et al. | β | 2017 | β |
| Genetic variation in the gene <i>LRP2</i> increases relapse risk in multiple sclerosis. | Zhou Y et al. | β | 2017 | β |
| Gene variants of adhesion molecules act as modifiers of disease severity in MS. | Dardiotis E et al. | β | 2017 | β |
| Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination. | Chen Y et al. | β | 2017 | β |
| Integrating genome-wide association studies and gene expression data highlights dysregulated multiple sclerosis risk pathways. | Liu G et al. | β | 2017 | β |
| Morgagnian cataract resulting from a naturally occurring nonsense mutation elucidates a role of CPAMD8 in mammalian lens development. | Hollmann AK et al. | β | 2017 | β |
| Multiple sclerosis risk pathways differ in Caucasian and Chinese populations. | Liu G et al. | β | 2017 | β |
| Osteoclast stimulation factor 1 (Ostf1) KNOCKOUT increases trabecular bone mass in mice. | Vermeren M et al. | β | 2017 | β |
| Role of LRRTMs in synapse development and plasticity. | Roppongi RT et al. | β | 2017 | β |
| Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. | Disanto G et al. | β | 2017 | β |
| Single-nucleotide polymorphism rs948854 in human galanin gene and multiple sclerosis: a gender-specific risk factor. | Lioudyno V et al. | β | 2017 | β |
| The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years. | Baranzini SE et al. | β | 2017 | β |
| TRIM proteins and diseases. | Watanabe M et al. | β | 2017 | β |
| Two unrelated children with overlapping 6q25.3 deletions, motor speech disorders, and language delays. | Peter B et al. | β | 2017 | β |
| A genetic basis for multiple sclerosis severity: Red herring or real? | Jokubaitis VG et al. | β | 2016 | β |
| Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis. | Aksoy D et al. | β | 2016 | β |
| Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk. | Xia Z et al. | β | 2016 | β |
| Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease. | Hao X et al. | β | 2016 | β |
| Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis. | Creanza TM et al. | β | 2016 | β |
| MicroRNAs targeting TGFΞ² signalling underlie the regulatory T cell defect in multiple sclerosis. | Severin ME et al. | β | 2016 | β |
| Multiple sclerosis: genetics, biomarkers, treatments. | Axisa PP et al. | β | 2016 | β |
| Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study. | Pan G et al. | β | 2016 | β |
| ZFAT gene variant association with multiple sclerosis in the Arabian Gulf population: A genetic basis for gender-associated susceptibility. | Bourguiba-Hachemi S et al. | β | 2016 | β |
| Advances in the immunopathogenesis of multiple sclerosis. | Yadav SK et al. | β | 2015 | β |
| Allele-Selective Transcriptome Recruitment to Polysomes Primed for Translation: Protein-Coding and Noncoding RNAs, and RNA Isoforms. | Mascarenhas R et al. | β | 2015 | β |
| Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis. | Giacalone G et al. | β | 2015 | β |
| A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches. | Bashinskaya VV et al. | β | 2015 | β |
| Association Between MTHFR Genetic Variants and Multiple Sclerosis in a Southern Iranian Population. | Naghibalhossaini F et al. | β | 2015 | β |
| Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran. | Haj MS et al. | β | 2015 | β |
| Class II HLA interactions modulate genetic risk for multiple sclerosis. | Moutsianas L et al. | β | 2015 | β |
| Functional relevance for multiple sclerosis-associated genetic variants. | Lin X et al. | β | 2015 | β |
| "GAG-ing with the neuron": The role of glycosaminoglycan patterning in the central nervous system. | Smith PD et al. | β | 2015 | β |
| Genetic associations with brain cortical thickness in multiple sclerosis. | Matsushita T et al. | β | 2015 | β |
| Genetic contribution to multiple sclerosis risk among Ashkenazi Jews. | Khankhanian P et al. | β | 2015 | β |
| Genetic determinants of risk and progression in multiple sclerosis. | Didonna A et al. | β | 2015 | β |
| Genetics and brain morphology. | Strike LT et al. | β | 2015 | β |
| Genomewide admixture study in Mexican Mestizos with multiple sclerosis. | OrdoΓ±ez G et al. | β | 2015 | β |
| Genome-wide Association Study of Postburn Scarring Identifies a Novel Protective Variant. | Sood RF et al. | β | 2015 | β |
| Genome-wide association study of posttraumatic stress disorder in a cohort of Iraq-Afghanistan era veterans. | Ashley-Koch AE et al. | β | 2015 | β |
| GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians. | Bashinskaya VV et al. | β | 2015 | β |
| Haplotype-based approach to known MS-associated regions increases the amount of explained risk. | Khankhanian P et al. | β | 2015 | β |
| Imaging phenotypes in multiple sclerosis. | Roosendaal SD et al. | β | 2015 | β |
| Involvement of CD8(+) T Cells in Multiple Sclerosis. | Salou M et al. | β | 2015 | β |
| Pharmacogenomics of interferon-Ξ² in multiple sclerosis: what has been accomplished and how can we ensure future progress? | Carlson RJ et al. | β | 2015 | β |
| Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study. | Lin X et al. | β | 2015 | β |
| XWAS: A Software Toolset for Genetic Data Analysis and Association Studies of the X Chromosome. | Gao F et al. | β | 2015 | β |
| Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases. | Chang D et al. | β | 2014 | β |
| A genome-wide association study identifies susceptibility loci of silica-related pneumoconiosis in Han Chinese. | Chu M et al. | β | 2014 | β |
| Association analysis of IL7R polymorphisms with inflammatory demyelinating diseases. | Kim JY et al. | β | 2014 | β |
| Association between multiple sclerosis risk-associated SNPs and relapse and disability--a prospective cohort study. | Lin R et al. | β | 2014 | β |
| Association between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease. | Liu Y et al. | β | 2014 | β |
| Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina. | Farez MF et al. | β | 2014 | β |
| Body fluid biomarkers in multiple sclerosis. | Comabella M et al. | β | 2014 | β |
| Current developments in pharmacogenomics of multiple sclerosis. | Carlson RJ et al. | β | 2014 | β |
| Frontotemporal dementia and its subtypes: a genome-wide association study. | Ferrari R et al. | β | 2014 | β |
| Genetic association of rs1520333 G/A polymorphism in the IL7 gene with multiple sclerosis susceptibility in Isfahan population. | Ghavimi R et al. | β | 2014 | β |
| Genetic Epidemiology of Psoriasis. | Gupta R et al. | β | 2014 | β |
| Genome-wide association studies in neurology. | Tan MS et al. | β | 2014 | β |
| Hope for GWAS: relevant risk genes uncovered from GWAS statistical noise. | Correia C et al. | β | 2014 | β |
| MACROD2 gene associated with autistic-like traits in a general population sample. | Jones RM et al. | β | 2014 | β |
| Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. | Friese MA et al. | β | 2014 | β |
| Multiple sclerosis genetics. | Cree BA | β | 2014 | β |
| Multiple sclerosis genetics. | Sawcer S et al. | β | 2014 | β |
| Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis. | Lin R et al. | β | 2014 | β |
| Prediction of response to interferon therapy in multiple sclerosis. | Sellebjerg F et al. | β | 2014 | β |
| Principal component analysis characterizes shared pathogenetics from genome-wide association studies. | Chang D et al. | β | 2014 | β |
| Profile of differential promoter activity by nucleotide substitution at GWAS signals for multiple sclerosis. | Ryu J et al. | β | 2014 | β |
| Protein interaction networks reveal novel autism risk genes within GWAS statistical noise. | Correia C et al. | β | 2014 | β |
| Remyelinating strategies in multiple sclerosis. | Luessi F et al. | β | 2014 | β |
| Sex- and age-interacting eQTLs in human complex diseases. | Yao C et al. | β | 2014 | β |
| Single nucleotide polymorphism (SNP)-strings: an alternative method for assessing genetic associations. | Goodin DS et al. | β | 2014 | β |
| The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients. | Heidary M et al. | β | 2014 | β |
| Warped linear mixed models for the genetic analysis of transformed phenotypes. | Fusi N et al. | β | 2014 | β |
| A genome-wide association study of brain lesion distribution in multiple sclerosis. | Gourraud PA et al. | β | 2013 | β |
| A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). | Rubicz R et al. | β | 2013 | β |
| A genome-wide integrative study of microRNAs in human liver. | Gamazon ER et al. | β | 2013 | β |
| A global map for dissecting phenotypic variants in human lincRNAs. | Ning S et al. | β | 2013 | β |
| A proximity-based method to identify genomic regions correlated with a continuously varying environmental variable. | Di Gaetano C et al. | β | 2013 | β |
| Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients. | Fekih Mrissa N et al. | β | 2013 | β |
| Association of multiple sclerosis susceptibility variants and early attack location in the CNS. | Mowry EM et al. | β | 2013 | β |
| Association of SNPs of CD40 gene with multiple sclerosis in Russians. | Sokolova EA et al. | β | 2013 | β |
| Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls. | Nickles D et al. | β | 2013 | β |
| Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patients. | LΓ³pez-GΓ³mez C et al. | β | 2013 | β |
| Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. | Ottoboni L et al. | β | 2013 | β |
| Contribution of genome-wide association studies to scientific research: a pragmatic approach to evaluate their impact. | Ricigliano VA et al. | β | 2013 | β |
| Fishing for biliary atresia susceptibility genes. | Miethke AG et al. | β | 2013 | β |
| From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A. | Berge T et al. | β | 2013 | β |
| Genetic burden in multiple sclerosis families. | Isobe N et al. | β | 2013 | β |
| Genetic risk variants in African Americans with multiple sclerosis. | Isobe N et al. | β | 2013 | β |
| Genome-wide association study identifies loci on 12q24 and 13q32 associated with tetralogy of Fallot. | Cordell HJ et al. | β | 2013 | β |
| Genome-wide association study of HLA-DQB1*06:02 negative essential hypersomnia. | Khor SS et al. | β | 2013 | β |
| Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study. | Apperson ML et al. | β | 2013 | β |
| Glutamate gene polymorphisms predict brain volumes in multiple sclerosis. | Strijbis EM et al. | β | 2013 | β |
| Identification of shared genes and pathways: a comparative study of multiple sclerosis susceptibility, severity and response to interferon beta treatment. | Mahurkar S et al. | β | 2013 | β |
| Identity-by-descent mapping to detect rare variants conferring susceptibility to multiple sclerosis. | Lin R et al. | β | 2013 | β |
| Interaction of <i>HLA-DRB1</i>*<i>1501</i> and <i>TNF-Alpha</i> in a Population-based Case-control Study of Multiple Sclerosis. | Williamson DM et al. | β | 2013 | β |
| Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study. | Bryant C et al. | β | 2013 | β |
| MRI characteristics of familial and sporadic multiple sclerosis patients. | Tipirneni A et al. | β | 2013 | β |
| Multiple sclerosis: individualized disease susceptibility and therapy response. | Pravica V et al. | β | 2013 | β |
| Multiple sclerosis susceptibility genes: associations with relapse severity and recovery. | Mowry EM et al. | β | 2013 | β |
| Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome. | Kalincik T et al. | β | 2013 | β |
| Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls. | International Multiple Sclerosis Genetics Consortium | β | 2013 | β |
| Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis. | Litwak SA et al. | β | 2013 | β |
| Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases. | Shin JG et al. | β | 2013 | β |
| Quantitative trait loci analysis reveals candidate genes implicated in regulating functional deficit and CNS vascular permeability in CD8 T cell-initiated blood-brain barrier disruption. | Johnson HL et al. | β | 2013 | β |
| Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes. | Cortes A et al. | β | 2013 | β |
| Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS. | He X et al. | β | 2013 | β |
| The Evi5 family in cellular physiology and pathology. | Lim YS et al. | β | 2013 | β |
| The genetics of innate immunity sensors and human disease. | Pothlichet J et al. | β | 2013 | β |
| The genetics of multiple sclerosis: review of current and emerging candidates. | MuΓ±oz-Culla M et al. | β | 2013 | β |
| The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort. | Qiu W et al. | β | 2013 | β |
| Towards a 'systems'-level understanding of the nervous system and its disorders. | Qureshi IA et al. | β | 2013 | β |
| Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis. | Atan D et al. | β | 2013 | β |
| A clear look at the neuroimmunology of multiple sclerosis and beyond. | Selmi C et al. | β | 2012 | β |
| A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis. | Wang L et al. | β | 2012 | β |
| Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease. | Al Jumah M et al. | β | 2012 | β |
| Childhood trauma in multiple sclerosis: a case-control study. | Spitzer C et al. | β | 2012 | β |
| Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. | Lill CM et al. | β | 2012 | β |
| Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe. | Rubio JP et al. | β | 2012 | β |
| Epistasis and immunity: the role of genetic interactions in autoimmune diseases. | Rose AM et al. | β | 2012 | β |
| From phenotype to genotype: an association study of longitudinal phenotypic markers to Alzheimer's disease relevant SNPs. | Wang H et al. | β | 2012 | β |
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | Edwards AC et al. | β | 2012 | β |
| Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. | Matesanz F et al. | β | 2012 | β |
| Genome-wide linkage meta-analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies. | EPICURE Consortium et al. | β | 2012 | β |
| Genomic imbalances detected by array-CGH in patients with syndromal ocular developmental anomalies. | Delahaye A et al. | β | 2012 | β |
| GPC5 rs2352028 polymorphism and risk of lung cancer in Han Chinese. | Zheng Y et al. | β | 2012 | β |
| Multiple sclerosis. | Nylander A et al. | β | 2012 | β |
| Next-generation sequencing approaches for genetic mapping of complex diseases. | Casals F et al. | β | 2012 | β |
| Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. | Cox MB et al. | β | 2012 | β |
| Progress in multiple sclerosis genetics. | Goris A et al. | β | 2012 | β |
| Protein-protein interaction analysis highlights additional loci of interest for multiple sclerosis. | Ragnedda G et al. | β | 2012 | β |
| Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients. | Schmied MC et al. | β | 2012 | β |
| Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers. | Pravica V et al. | β | 2012 | β |
| [The genetic profile of multiple sclerosis: risk genes and the "dark matter"]. | Lill CM et al. | β | 2012 | β |
| The genetics of multiple sclerosis. | Lin R et al. | β | 2012 | β |
| The genetics of multiple sclerosis: an up-to-date review. | Gourraud PA et al. | β | 2012 | β |
| Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. | Gourraud PA et al. | β | 2011 | β |
| Analysis of potential genomic confounding in genetic association studies and an online genomic confounding browser (GCB). | Raistrick CA et al. | β | 2011 | β |
| Association between the IL7R T244I polymorphism and multiple sclerosis: a meta-analysis. | Zhang R et al. | β | 2011 | β |
| Clinical biomarkers in multiple sclerosis. | Rose JW et al. | β | 2011 | β |
| Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes. | Ross KA | β | 2011 | β |
| Filtering the genes and sorting the glomerular filter: a new piece in the puzzle? | Kleta R et al. | β | 2011 | β |
| Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. | Paraboschi EM et al. | β | 2011 | β |
| Genetic correlations of brain lesion distribution in multiple sclerosis: an exploratory study. | Sombekke MH et al. | β | 2011 | β |
| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. | International Multiple Sclerosis Genetics Consortium et al. | β | 2011 | β |
| Genome-wide association studies in multiple sclerosis: lessons and future prospects. | Kemppinen A et al. | β | 2011 | β |
| Genome-wide association study of severity in multiple sclerosis. | International Multiple Sclerosis Genetics Consortium | β | 2011 | β |
| GPC5 gene and its related pathways in lung cancer. | Li Y et al. | β | 2011 | β |
| Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. | Roosendaal SD et al. | β | 2011 | β |
| HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event. | Horakova D et al. | β | 2011 | β |
| HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. | Romero-Pinel L et al. | β | 2011 | β |
| Inflammatory profile, age of onset, and the MTHFR polymorphism in patients with multiple sclerosis. | Alatab S et al. | β | 2011 | β |
| Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis. | Suzuki A et al. | β | 2011 | β |
| Interleukin 2 receptor Ξ± gene polymorphism and risk of multiple sclerosis: a meta-analysis. | Wang LM et al. | β | 2011 | β |
| Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex. | Zuvich RL et al. | β | 2011 | β |
| Is there any association between multiple sclerosis and familial Mediterranean fever? | Zahednasab H et al. | β | 2011 | β |
| Just in time: an update on continuum neurogenetics. | Rost NS | β | 2011 | β |
| Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. | Guerau-de-Arellano M et al. | β | 2011 | β |
| Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. | Wang JH et al. | β | 2011 | β |
| More CLEC16A gene variants associated with multiple sclerosis. | Nischwitz S et al. | β | 2011 | β |
| Multiple sclerosis genetics 2010. | McElroy JP et al. | β | 2011 | β |
| Myelin regeneration in multiple sclerosis: targeting endogenous stem cells. | Huang JK et al. | β | 2011 | β |
| [New gene map for multiple sclerosis]. | Harbo HF et al. | β | 2011 | β |
| Performance of genotype imputation for rare variants identified in exons and flanking regions of genes. | Li L et al. | β | 2011 | β |
| Polymorphisms in genes encoding leptin, ghrelin and their receptors in German multiple sclerosis patients. | Rey LK et al. | β | 2011 | β |
| Progressive multiple sclerosis: characteristics and management. | Hawker K | β | 2011 | β |
| Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis. | Sombekke MH et al. | β | 2011 | β |
| Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. | Cavanillas ML et al. | β | 2011 | β |
| Revealing the genetic basis of multiple sclerosis: are we there yet? | Baranzini SE | β | 2011 | β |
| Revisiting the T-cell receptor alpha/delta locus and possible associations with multiple sclerosis. | Watson CT et al. | β | 2011 | β |
| Risk conferring genes in multiple sclerosis. | Nischwitz S et al. | β | 2011 | β |
| Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases. | Musone SL et al. | β | 2011 | β |
| SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients. | McElroy JP et al. | β | 2011 | β |
| Systematic review of genome-wide expression studies in multiple sclerosis. | Kemppinen AK et al. | β | 2011 | β |
| TRAIL/TRAIL receptor system and susceptibility to multiple sclerosis. | LΓ³pez-GΓ³mez C et al. | β | 2011 | β |
| Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. | Couturier N et al. | β | 2011 | β |
| Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection. | Vandenbroeck K et al. | β | 2011 | β |
| A genome-wide scan for common alleles affecting risk for autism. | Anney R et al. | β | 2010 | β |
| Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. | Lindberg RL et al. | β | 2010 | β |
| Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. | Saykin AJ et al. | β | 2010 | β |
| Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis. | Sombekke MH et al. | β | 2010 | β |
| A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis. | Ban M et al. | β | 2010 | β |
| A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis. | Mero IL et al. | β | 2010 | β |
| Association to the Glypican-5 gene in multiple sclerosis. | Lorentzen AR et al. | β | 2010 | β |
| A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis. | Riveros C et al. | β | 2010 | β |
| CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. | Bronson PG et al. | β | 2010 | β |
| Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. | International Multiple Sclerosis Genetics Consortium (IMSGC) | β | 2010 | β |
| Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals. | Briggs FB et al. | β | 2010 | β |
| Fine mapping of T-cell immunoglobulin mucin domain gene 1 failed to detect a significant association with multiple sclerosis. | Grabmer C et al. | β | 2010 | β |
| Fungal toxins and multiple sclerosis: a compelling connection. | Purzycki CB et al. | β | 2010 | β |
| Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. | Li Y et al. | β | 2010 | β |
| Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis. | Baranzini SE et al. | β | 2010 | β |
| Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. | Zuvich RL et al. | β | 2010 | β |
| Genome-wide association analysis in primary sclerosing cholangitis. | Karlsen TH et al. | β | 2010 | β |
| Genome-wide association studies: a powerful tool for neurogenomics. | Cowperthwaite MC et al. | β | 2010 | β |
| Genome-wide identification of susceptibility alleles for viral infections through a population genetics approach. | Fumagalli M et al. | β | 2010 | β |
| GPC5 and lung cancer in multiple sclerosis. | Handel AE et al. | β | 2010 | β |
| Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. | Disanto G et al. | β | 2010 | β |
| HLA B*44: protective effects in MS susceptibility and MRI outcome measures. | Healy BC et al. | β | 2010 | β |
| HLA-class I markers and multiple sclerosis susceptibility in the Italian population. | Bergamaschi L et al. | β | 2010 | β |
| IFN-beta pharmacogenomics in multiple sclerosis. | Vandenbroeck K et al. | β | 2010 | β |
| IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. | International Multiple Sclerosis Genetics Conssortium (IMSGC) | β | 2010 | β |
| Multiple sclerosis genetics--is the glass half full, or half empty? | Oksenberg JR et al. | β | 2010 | β |
| Multiple sclerosis susceptibility alleles in African Americans. | Johnson BA et al. | β | 2010 | β |
| Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients. | Jensen CJ et al. | β | 2010 | β |
| Overcoming remyelination failure in multiple sclerosis and other myelin disorders. | Fancy SP et al. | β | 2010 | β |
| Polymorphic cis- and trans-regulation of human gene expression. | Cheung VG et al. | β | 2010 | β |
| Refining the association of MHC with multiple sclerosis in African Americans. | McElroy JP et al. | β | 2010 | β |
| RGMA and IL21R show association with experimental inflammation and multiple sclerosis. | Nohra R et al. | β | 2010 | β |
| Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study. | La Russa A et al. | β | 2010 | β |
| The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. | Alcina A et al. | β | 2010 | β |
| The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression. | Handel AE et al. | β | 2010 | β |
| The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. | Gandhi KS et al. | β | 2010 | β |
| The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility. | Bahreini SA et al. | β | 2010 | β |
| Uncovering the genetic architecture of multiple sclerosis. | Esposito F et al. | β | 2010 | β |
| Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. | Shen L et al. | β | 2010 | β |
| Advances in the molecular imaging of multiple sclerosis. | Matthews PM et al. | β | 2009 | β |
| Antiviral immune responses: triggers of or triggered by autoimmunity? | MΓΌnz C et al. | β | 2009 | β |
| A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis. | Jagodic M et al. | β | 2009 | β |
| Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility. | MΓ‘rquez A et al. | β | 2009 | β |
| European Charcot Foundation Lecture: the natural history of multiple sclerosis and gender. | Sadovnick AD | β | 2009 | β |
| From genes to function: the next challenge to understanding multiple sclerosis. | Fugger L et al. | β | 2009 | β |
| HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). | FernΓ‘ndez O et al. | β | 2009 | β |
| Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future. | De Jager PL | β | 2009 | β |
| Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. | De Jager PL et al. | β | 2009 | β |
| Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1. | Enevold C et al. | β | 2009 | β |
| Multiple sclerosis and the major histocompatibility complex. | Ramagopalan SV et al. | β | 2009 | β |
| Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. | Baranzini SE et al. | β | 2009 | β |
| Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. | Hoppenbrouwers IA et al. | β | 2009 | β |
| Strategies and issues in the detection of pathway enrichment in genome-wide association studies. | Hong MG et al. | β | 2009 | β |
| The genetic aspects of multiple sclerosis. | Sawcer S | β | 2009 | β |
| The genetics of autoimmune diseases: a networked perspective. | Baranzini SE | β | 2009 | β |
| Using prior knowledge and genome-wide association to identify pathways involved in multiple sclerosis. | Ritchie MD | β | 2009 | β |